At a glance
ClinicalIndex Comparison RecordN/ACompleted· 72 enrolled
Drug / intervention
Docusate +1 moredrug
Likely dose
Docusate 100mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Bowel Function After Minimally Invasive Urogynecologic Surgery: A Prospective Randomized Controlled Trial
In Brief
A clinical study evaluating Docusate and Bowel medications for Functional Disorder of Intestine. Completed, enrolled 72 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the effect of a standardized postoperative bowel regimen of over-the-counter medications in subjects undergoing minimally invasive urogynecologic surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFunctional Disorder of Intestine
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2009
First PostedJan 2010
Primary CompletionFeb 2011
TodayJul 2026
First PostedJan 7, 2010
Enrollment StartNov 1, 2009
Primary CompletionFeb 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 16.5 years ago
Interventions
Docusatedrug
Docusate 100mg BID
Bowel medicationsdrug
Docusate 100mg BID Metamucil fiber wafers - 2 wafers daily Miralax 1 packet daily Bisacodyl 1 suppository BID